BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12868359)

  • 1. [Homocysteine and coronary artery disease].
    Aro A
    Duodecim; 2003; 119(12):1131-5. PubMed ID: 12868359
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention.
    Woo KS; Qiao M; Chook P; Poon PY; Chan AK; Lau JT; Fung KP; Woo JL
    J Card Surg; 2002; 17(5):432-5. PubMed ID: 12630544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine: a new cardiac risk factor?
    Chai AU; Abrams J
    Clin Cardiol; 2001 Jan; 24(1):80-4. PubMed ID: 11195611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine levels and cardiovascular risk in Indians.
    Karthikeyan G; Prabhakaran D; Reddy KS
    J Assoc Physicians India; 2002 May; 50 Suppl():24-8. PubMed ID: 12186152
    [No Abstract]   [Full Text] [Related]  

  • 5. Homocysteinylation of metallothionein impairs intracellular redox homeostasis: the enemy within!
    Colgan SM; Austin RC
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):8-11. PubMed ID: 17185621
    [No Abstract]   [Full Text] [Related]  

  • 6. Helicobacter pylori infection does not affect the serum level of homocysteine.
    Yoshino N; Adachi K; Takashima T; Miyaoka Y; Yuki T; Ishihara S; Kinoshita Y
    Am J Gastroenterol; 2002 Nov; 97(11):2927-8. PubMed ID: 12425577
    [No Abstract]   [Full Text] [Related]  

  • 7. Homocysteine and coronary risk.
    Seshadri N; Robinson K
    Curr Cardiol Rep; 1999 Jul; 1(2):91-8. PubMed ID: 10980826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of (early) folate status to primary and secondary coronary artery disease prevention.
    Muskiet FA
    Reprod Toxicol; 2005; 20(3):403-10. PubMed ID: 15964170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing coronary artery disease by decreasing homocysteine levels.
    Coffey M; Crowder GK; Cheek DJ
    Crit Care Nurse; 2003 Feb; 23(1):25-30. PubMed ID: 12640957
    [No Abstract]   [Full Text] [Related]  

  • 10. Homocysteine: the latest risk factor for heart disease.
    Reeder SJ; Hoffmann RL; Magdic KS; Rodgers JM
    Dimens Crit Care Nurs; 2000; 19(1):22-8. PubMed ID: 10876482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
    De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
    Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and coronary microcirculation: is it a microvasculopathic agent?
    Turhan H; Aksoy Y; Yetkin E
    Int J Cardiol; 2006 Jun; 110(2):269-70. PubMed ID: 16325281
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential role of homocysteine in percutaneous coronary interventions (PCI): review of current evidence and plausibility of action.
    Stanger O
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):953-88. PubMed ID: 15704259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults.
    Carlsson CM; Pharo LM; Aeschlimann SE; Mitchell C; Underbakke G; Stein JH
    Am Heart J; 2004 Sep; 148(3):E11. PubMed ID: 15389247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of homocysteine and coronary artery disease.
    Gauthier GM; Keevil JG; McBride PE
    Clin Cardiol; 2003 Dec; 26(12):563-8. PubMed ID: 14677809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary risk attributes, coronary risk reduction, and clinical outcomes.
    Wenger NK; Weber MA; Scheidt S
    Am J Geriatr Cardiol; 2006; 15(3):140-1. PubMed ID: 16687965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.